The Manchester Interdisciplinary Biocentre (MIB) is officially opening on 25/26th October 2006. The centre has been about a decade in the making, and aims to be a world-class research centre, with around £37 million (~$70 million) of initial funding from the Wellcome Trust charity, UK Research Councils and others. If you’re looking for a bioinformatics job, PhD, PostDoc etc in the UK, MIB is continuously hiring and looks like a good place to work, if the opening programme (which follows) is anything to go by.
Unfortunately the MIB web pages aren’t quite world class yet, the promotional launch material is only available in pdf format, *sigh*, see references below. So I’m blogging the MIB Symposium launch programme here to put the stuff online. Talks scheduled for the second day of the opening, 26th October 2006, are listed below, and these can be attended by free registration (see references):
Session 1: Bio-molecular machines, 9.00-11.00
Session chaired by Alan North, Dean of the Faculty of Life Sciences
- John E. Walker (MRC Dunn Human Nutrition Unit, Cambridge, UK): Biomolecular rotary motors.
- Yoshi Nakamura (Tokyo University, Japan): Aptamer as RNA-made super antibody for basic and therapeutic applications
- John McCarthy, (Manchester Interdisciplinary Biocentre): Molecular mechanisms underlying post-transcrptional gene expression.
- Refreshment break
Session 2: Biomolecular Structure and Dynamics, 11.00-12.40
Session chaired by Bob Ford, Professor of Structural Biology, Faculty of Life Sciences.
Session 3: Systems and Information, 13.35-15.45
Session chaired by John Perkins, Dean of Faculty of Engineering and Physical Sciences.
Session 4: Biocatalysis, 16.10-17.00
Session chaired by Hans Westerhoff, Manchester Interdisciplinary Biocentre
- Nigel Scrutton (MIB and Faculty of Life Sciences): ‘Squeezing’ barriers – a dynamical view of enzyme catalysis.
- Gill Stephens, (MIB and School of Chemical Engineering): Redox biocatalysis – the next generation of enzymes for manufacturing pharmaceutical intermediates and specialty chemicals.
Session 5: Bionanoscience and engineering: 17.00-18.00
Session chaired by Peter Fielden, Chemical Engineering
- Joseph Wang (Arizona State University, USA): Nanomaterials for monitoring and controlling biomolecular interactions.
- Milan Stojanovich (Columbia University Medical School, New York, USA): Deoxyribozyme-based devices.
Session 6: Postgenomic Analytical Technologies, 18.00-19.10
Session chaired by Roy Goodacre, MIB and School of Chemistry
- Ruedi Aebersold (ETH Zürich): Quantitative Proteomics and Systems Biology
- Simon Gaskell, MIB and School of Chemistry: New analytical science in proteomics and metabolomics.
- Concluding remarks.
MEDIE is an “intelligent” semantic search engine that retrieves biomedical correlations from over 14 million articles in MEDLINE. You can find abstracts and sentences in MEDLINE by specifying the semantics of correlations; for example, What activates tumour suppressor protein p53? So just how useful is MEDIE and is it at the cutting edge?
O'Really? 